StockData
Mangoceuticals, Inc. logo

Mangoceuticals, Inc. (MGRX) stock

MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$0.13−0.01 (-8.74%)

Close on Nov 19, 2026Market cap $2.88MP/E –Yield –

Mangoceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Mangoceuticals's gross profit for the twelve months ending Jun 30, 2026 was $171.59K, down 45.5% year over year. For fiscal 2025 it was $250.39K, down 34.1% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$250.39K-34.1%
FY2024Dec 31, 2024$379.96K-11.9%
FY2023Dec 31, 2023$431.50K+8796.9%
FY2022Dec 31, 2022$4.85K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$44.22K-50.8%
Q1 FY2026Mar 31, 2026$29.00K-53.3%
Q4 FY2025Dec 31, 2025$47.48K-40.7%
Q3 FY2025Sep 30, 2025$50.90K-38.4%
Q2 FY2025Jun 30, 2025$89.95K+28.9%
Q1 FY2025Mar 31, 2025$62.06K-57.9%
Q4 FY2024Dec 31, 2024$80.10K-43.8%
Q3 FY2024Sep 30, 2024$82.67K-42.8%
Q2 FY2024Jun 30, 2024$69.79K-19.9%
Q1 FY2024Mar 31, 2024$147.40K+157.7%
Q4 FY2023Dec 31, 2023$142.58K–
Q3 FY2023Sep 30, 2023$144.59K–
Q2 FY2023Jun 30, 2023$87.13K–
Q1 FY2023Mar 31, 2023$57.20K–

More Mangoceuticals figures

See a number that looks wrong?